11-Sep-2018 | Zion Market Research
Zion Market Research has published a new report titled “Hematology Analyzers and Reagents Market by Product (Instruments [Hematology Analyzers, Hemostasis Analyzers, Plasma Protein Analyzers, Coagulation Analyzers and Other Analyzers], Reagents and Consumables, and Services), by Application (Anemia, Blood Cancer, Hemorrhagic Conditions, Infection Related Conditions, Immune System Related Conditions, and Others), and by End-User (Hospitals, Commercial Service Providers, Reference Laboratories, and Research and Academic Institutes): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024”. According to the report, global hematology analyzers and reagents market was valued at approximately USD 2.99 billion in 2017 and is expected to generate revenue of around USD 5.09 billion by end of 2024, growing at a CAGR of around 7.90% between 2018 and 2024.
Rising innovation in the field of pharmacogenomics, genetic therapies, bleeding disorders, stem cell research, and proteomics are anticipated to propel the hematology analyzers and reagents market over the forecast period. Likewise, factors such as consolidation of diagnostic laboratory chains and rising public awareness are also driving the growth of the market, and this trend is expected to continue in the years to come.
Browse the full "Hematology Analyzers and Reagents Market by Product (Instruments [Hematology Analyzers, Hemostasis Analyzers, Plasma Protein Analyzers, Coagulation Analyzers and Other Analyzers], Reagents and Consumables, and Services), by Application (Anemia, Blood Cancer, Hemorrhagic Conditions, Infection Related Conditions, Immune System Related Conditions, and Others), and by End-User (Hospitals, Commercial Service Providers, Reference Laboratories, and Research and Academic Institutes): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024" report at https://www.zionmarketresearch.com/report/hematology-analyzers-and-reagents-market
The hematology analyzers and reagents market are segmented on the basis of product into instruments, reagents and consumables, and services. The instruments segment is further divided into hematology analyzers, hemostasis analyzers, plasma protein analyzers, coagulation analyzers, and other analyzers. The hematology analyzers are further bifurcated into 3-part fully automated hematology analyzers, point-of-care testing hematology analyzers, 5-part and 6-part fully automated hematology analyzers, and semi-automated hematology analyzers. The instruments segment held a major share of the hematology analyzers and reagents market owing to the growing demand for these instruments from the end users. Due to the increasing adoption rate of the automated hematology instruments along with the growing demand for highly sensitive hematology testing is likely to drive the market for instruments segment in the forecast period. Also, rising developments in high-end technology like the introduction of basic cytometry techniques analyzers and the expansion of high throughput hematology analyzers is been propelling industry growth.
The hematology analyzers and reagents market are segmented on the basis of an application which is further divided into anemia, blood cancer, hemorrhagic conditions, infection-related conditions, conditions related to immune system, and others. The anemia’s application segment held the largest share of the market owing to the rising prevalence of sickle cell disease and blood-related disorders.
Based on the end user, the market is segmented into commercial service providers, hospitals, reference laboratories, and research and academic institutes. Of these, the hospitals and commercial service providers contributed for a larger pie of the market share in 2017 and are anticipated to witness the highest growth rate during the forecast period. Factors such as rising prevalence of blood disorders, sickle cell disease, chronic lead poisoning, cytochemistries on blood and bone marrow, chronic granulomatous disease, identification of abnormal hemoglobin’s and other such tests and treatments are mostly carried under these two segments.
Regionally, the market for hematology analyzer and reagents is segmented into North America, Latin America, Asia Pacific, Europe, and the Middle East & Africa. North America is the leading contributor of the hematology analyzers and reagents market like anemia and cancer, development in healthcare facilities, rising healthcare awareness among the population, increase in a number of highly advanced diagnostic clinics are some of the other factors contributing to the growth for the hematology analyzer and reagents market in this region.
Some of the leading players in hematology analyzers and reagents market include Abbott Diagnostics, Bio-Rad Laboratories, Drew Scientific, Sysmex Corporation, Siemens AG, Bayer Healthcare, Beckman Coulter, Heska Corporation, Danaher Corporation, and Cholestech Corporation.
This report segments the global hematology analyzers and reagents market as follows:
Global Hematology Analyzers and Reagents Market: Product Segment Analysis
Global Hematology Analyzers and Reagents Market: Application Segment Analysis
Global Hematology Analyzers and Reagents Market: End-User Segment Analysis
Global Hematology Analyzers and Reagents Market: Regional Segment Analysis
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651